[1]
M. L. . BRODT-LEMES, “Budget impact analysis of the incorporating of biosimilars in a cancer institute of a philanthropic hospital”, J Hosp Pharm Health Serv, vol. 15, no. 3, p. e1130, Sep. 2024.